Antigen-specific T-cell response induction

Antigen-specific T-cell response induction refers to the priming and expansion of T cells that recognize a particular antigen through their T-cell receptors engaging peptide–MHC on antigen-presenting cells, followed by differentiation into effector and memory subsets that mediate adaptive immunity in infection, cancer, vaccination, and tolerance contexts.[4][6] In vaccination, rapid induction of antigen-specific CD4+ Th1 and circulating T follicular helper (cTfh) cells coordinates CD8+ T-cell responses and antibody production, with pre-boost Th1 and cTfh frequencies correlating with post-boost CD8+ T cells and neutralizing titers.[2] In contrast, tolerance-focused induction (“inverse vaccination”) aims to delete, anergize, or regulate antigen-specific effector T cells and to expand antigen-specific regulatory T cells using approaches such as tolerogenic dendritic cells, peptide/protein delivery, gene vaccination, or nanoparticle vehicles.[3][7] Experimental and clinical tracking of antigen-specific T cells uses peptide–MHC multimers/tetramers and functional or activation-induced marker assays to quantify and phenotype these cells over time, including shifts from IL-4–producing effectors to IL-10/FOXP3-expressing regulatory cells during allergen immunotherapy.[4][5]

Other names

Antigen-specific T-cell primingAntigen-specific T-cell activationAntigen-specific T-cell immunity inductionAntigen-specific tolerance induction (distinct, tolerance-focused usage)

Vaccine antigens and adjuvants prime antigen-specific CD4+ Th1/Tfh and CD8+ T cells via TCR recognition of peptide–MHC on antigen-presenting cells, leading to coordinated cellular and humoral immunity Tolerance-oriented strategies (inverse vaccination, tolerogenic dendritic cells, peptide/protein delivery, nanoparticles) induce antigen-specific anergy/deletion or expand Tregs to suppress pathogenic Teff responses